{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:22:37Z","timestamp":1783635757905,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":91,"publisher":"Springer US","isbn-type":[{"value":"9781071650493","type":"print"},{"value":"9781071650509","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5050-9_21","type":"book-chapter","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:05:23Z","timestamp":1783634723000},"page":"291-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancements in Circulating Tumor Cell Expansion Ex Vivo: A Matured Technology?"],"prefix":"10.1007","author":[{"given":"Jerry","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"21_CR1","unstructured":"Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Australasian Med J 1869:146\u2013147"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/bjc.1995.324","volume":"72","author":"P Johnson","year":"1995","unstructured":"Johnson P, Burchill S, Selby P (1995) The molecular detection of circulating tumour cells. Br J Cancer 72:268\u2013276. https:\/\/doi.org\/10.1038\/bjc.1995.324","journal-title":"Br J Cancer"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1073\/pnas.95.8.4589","volume":"95","author":"E Racila","year":"1998","unstructured":"Racila E, Euhus D, Weiss AJ et al (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95:4589\u20134594. https:\/\/doi.org\/10.1073\/pnas.95.8.4589","journal-title":"Proc Natl Acad Sci USA"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/biomedicines9091111","volume":"9","author":"J Xiao","year":"2021","unstructured":"Xiao J, Pohlmann PR, Isaacs C et al (2021) Circulating tumor cells: technologies and their clinical potential in cancer metastasis. Biomedicines 9:1111. https:\/\/doi.org\/10.3390\/biomedicines9091111","journal-title":"Biomedicines"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1158\/1078-0432.ccr-08-0872","volume":"14","author":"JS Bono","year":"2008","unstructured":"Bono JS, de, Scher HI, Montgomery RB et al (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14:6302\u20136309. https:\/\/doi.org\/10.1158\/1078-0432.ccr-08-0872","journal-title":"Clin Cancer Res"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1373\/clinchem.2011.175570","volume":"58","author":"K Pantel","year":"2012","unstructured":"Pantel K, Den\u00e8ve E, Nocca D et al (2012) Circulating epithelial cells in patients with benign colon diseases. Clin Chem 58:936\u2013940. https:\/\/doi.org\/10.1373\/clinchem.2011.175570","journal-title":"Clin Chem"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1200\/jco.2013.51.7417","volume":"32","author":"A Goldkorn","year":"2014","unstructured":"Goldkorn A, Ely B, Quinn DI et al (2014) Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. J Clin Oncol 32:1136\u20131142. https:\/\/doi.org\/10.1200\/jco.2013.51.7417","journal-title":"J Clin Oncol"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1373\/clinchem.2019.305904","volume":"65","author":"R Garrel","year":"2019","unstructured":"Garrel R, Mazel M, Perriard F et al (2019) Circulating tumor cells as a prognostic factor in recurrent or metastatic head and neck squamous cell carcinoma: the CIRCUTEC Prospective Study. Clin Chem 65:1267\u20131275. https:\/\/doi.org\/10.1373\/clinchem.2019.305904","journal-title":"Clin Chem"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1002\/cncr.23852","volume":"113","author":"S Dawood","year":"2008","unstructured":"Dawood S, Broglio K, Valero V et al (2008) Circulating tumor cells in metastatic breast cancer. Cancer 113:2422\u20132430. https:\/\/doi.org\/10.1002\/cncr.23852","journal-title":"Cancer"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580\u2013584. https:\/\/doi.org\/10.1126\/science.1228522","journal-title":"Science"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.1253533","volume":"345","author":"M Yu","year":"2014","unstructured":"Yu M, Bardia A, Aceto N et al (2014) Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345:216\u2013220. https:\/\/doi.org\/10.1126\/science.1253533","journal-title":"Science"},{"key":"21_CR12","doi-asserted-by":"publisher","unstructured":"Stott SL, Lee RJ, Nagrath S, et al (2010) Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2:25ra23\u201325ra23. https:\/\/doi.org\/10.1126\/scitranslmed.3000403","DOI":"10.1126\/scitranslmed.3000403"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nature11217","volume":"487","author":"M Yu","year":"2012","unstructured":"Yu M, Ting DT, Stott SL et al (2012) RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487:510\u2013513. https:\/\/doi.org\/10.1038\/nature11217","journal-title":"Nature"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/ijc.29212","volume":"136","author":"A Goldkorn","year":"2015","unstructured":"Goldkorn A, Ely B, Tangen CM et al (2015) Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial. Int J Cancer 136:1856\u20131862. https:\/\/doi.org\/10.1002\/ijc.29212","journal-title":"Int J Cancer"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT et al (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158:1110\u20131122. https:\/\/doi.org\/10.1016\/j.cell.2014.07.013","journal-title":"Cell"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-med-050311-163404","volume":"64","author":"M Balic","year":"2013","unstructured":"Balic M, Williams A, Lin H et al (2013) Circulating tumor cells: from bench to bedside. Annu Rev Med 64:31\u201344. https:\/\/doi.org\/10.1146\/annurev-med-050311-163404","journal-title":"Annu Rev Med"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"180ra48","DOI":"10.1126\/scitranslmed.3005109","volume":"5","author":"L Zhang","year":"2013","unstructured":"Zhang L, Ridgway LD, Wetzel MD et al (2013) The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med 5:180ra48\u2013180ra48. https:\/\/doi.org\/10.1126\/scitranslmed.3005109","journal-title":"Sci Transl Med"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3390\/cells8101145","volume":"8","author":"T Tayoun","year":"2019","unstructured":"Tayoun T, Faugeroux V, Oulhen M et al (2019) CTC-derived models: a window into the seeding\u00a0capacity of circulating tumor cells (CTCs).\u00a0Cells 8:1145. https:\/\/doi.org\/10.3390\/cells8101145","journal-title":"Cells"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nbt.2576","volume":"31","author":"I Baccelli","year":"2013","unstructured":"Baccelli I, Schneeweiss A, Riethdorf S et al (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31:539\u2013544. https:\/\/doi.org\/10.1038\/nbt.2576","journal-title":"Nat Biotechnol"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1039\/c3lc51017d","volume":"14","author":"W Sheng","year":"2013","unstructured":"Sheng W, Ogunwobi OO, Chen T et al (2013) Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab Chip 14:89\u201398. https:\/\/doi.org\/10.1039\/c3lc51017d","journal-title":"Lab Chip"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"12383","DOI":"10.18632\/oncotarget.2592","volume":"5","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Shiratsuchi H, Lin J et al (2014) Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget 5:12383\u201312397. https:\/\/doi.org\/10.18632\/oncotarget.2592","journal-title":"Oncotarget"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A et al (2014) Organoid cultures derived from patients with advanced prostate cancer. Cell 159:176\u2013187. https:\/\/doi.org\/10.1016\/j.cell.2014.08.016","journal-title":"Cell"},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/0008-5472.can-14-2613","volume":"75","author":"L Cayrefourcq","year":"2015","unstructured":"Cayrefourcq L, Mazard T, Joosse S et al (2015) Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res 75:892\u2013901. https:\/\/doi.org\/10.1158\/0008-5472.can-14-2613","journal-title":"Cancer Res"},{"key":"21_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jim.2013.05.001","volume":"394","author":"EC So","year":"2013","unstructured":"So EC, Sallin MA, Zhang X et al (2013) A high throughput method for enrichment of natural killer cells and lymphocytes and assessment of in vitro cytotoxicity. J Immunol Methods 394:40\u201348. https:\/\/doi.org\/10.1016\/j.jim.2013.05.001","journal-title":"J Immunol Methods"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"a030536","DOI":"10.1101\/cshperspect.a030536","volume":"8","author":"GP Risbridger","year":"2018","unstructured":"Risbridger GP, Toivanen R, Taylor RA (2018) Preclinical models of prostate cancer: patient-derived xenografts, organoids, and other explant models. CSH Perspect Med 8:a030536. https:\/\/doi.org\/10.1101\/cshperspect.a030536","journal-title":"CSH Perspect Med"},{"key":"21_CR26","doi-asserted-by":"publisher","unstructured":"Zhang Y, Men Y, Wang J et al (2021) Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC. J Cancer Res Clin 1\u201310. https:\/\/doi.org\/10.1007\/s00432-021-03681-9","DOI":"10.1007\/s00432-021-03681-9"},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1158\/1078-0432.ccr-14-1913","volume":"21","author":"C Paoletti","year":"2015","unstructured":"Paoletti C, Muniz MC, Thomas DG et al (2015) Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. Clin Cancer Res 21:2487\u20132498. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-1913","journal-title":"Clin Cancer Res"},{"key":"21_CR28","doi-asserted-by":"publisher","first-page":"e0173593","DOI":"10.1371\/journal.pone.0173593","volume":"12","author":"BAS Jaeger","year":"2017","unstructured":"Jaeger BAS, Neugebauer J, Andergassen U et al (2017) The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: a translational research project of a prospective randomized phase III trial. PLoS ONE 12:e0173593. https:\/\/doi.org\/10.1371\/journal.pone.0173593","journal-title":"PLoS ONE"},{"key":"21_CR29","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.molonc.2016.04.006","volume":"10","author":"C Paoletti","year":"2016","unstructured":"Paoletti C, Larios JM, Mu\u00f1iz MC et al (2016) Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance. Mol Oncol 10:1078\u20131085. https:\/\/doi.org\/10.1016\/j.molonc.2016.04.006","journal-title":"Mol Oncol"},{"key":"21_CR30","doi-asserted-by":"publisher","first-page":"e33788","DOI":"10.1371\/journal.pone.0033788","volume":"7","author":"AA Powell","year":"2012","unstructured":"Powell AA, Talasaz AH, Zhang H et al (2012) Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 7:e33788. https:\/\/doi.org\/10.1371\/journal.pone.0033788","journal-title":"PLoS ONE"},{"key":"21_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24386-0","volume":"12","author":"Y-F Sun","year":"2021","unstructured":"Sun Y-F, Wu L, Liu S-P et al (2021) Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nat Commun 12: 4091. https:\/\/doi.org\/10.1038\/s41467-021-24386-0","journal-title":"Nat Commun"},{"key":"21_CR32","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1158\/0008-5472.can-09-2111","volume":"69","author":"DR Hurst","year":"2009","unstructured":"Hurst DR, Edmonds MD, Welch DR (2009) Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69:7495\u20137498. https:\/\/doi.org\/10.1158\/0008-5472.can-09-2111","journal-title":"Cancer Res"},{"key":"21_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.02.039","volume":"423","author":"K Tan","year":"2018","unstructured":"Tan K, Leong SM, Kee Z et al (2018) Longitudinal monitoring reveals dynamic changes in circulating tumor cells (CTCs) and CTC-associated miRNAs in response to chemotherapy in metastatic colorectal cancer patients. Cancer Lett 423:1\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2018.02.039","journal-title":"Cancer Lett"},{"key":"21_CR34","doi-asserted-by":"publisher","unstructured":"Reza KK, Dey S, Wuethrich A et al (2021) In situ single cell proteomics reveals circulating tumor cell heterogeneity during treatment. ACS Nano https:\/\/doi.org\/10.1021\/acsnano.0c10008","DOI":"10.1021\/acsnano.0c10008"},{"key":"21_CR35","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1158\/0008-5472.can-12-4140","volume":"73","author":"E Heitzer","year":"2013","unstructured":"Heitzer E, Auer M, Gasch C et al (2013) Complextumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 73:2965\u20132975. https:\/\/doi.org\/10.1158\/0008-5472.can-12-4140","journal-title":"Cancer Res"},{"key":"21_CR36","doi-asserted-by":"publisher","first-page":"e0123902","DOI":"10.1371\/journal.pone.0123902","volume":"10","author":"A Lyberopoulou","year":"2015","unstructured":"Lyberopoulou A, Aravantinos G, Efstathopoulos EP et al (2015) Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. PLoS ONE 10:e0123902. https:\/\/doi.org\/10.1371\/journal.pone.0123902","journal-title":"PLoS ONE"},{"key":"21_CR37","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1038\/s41598-017-04601-z","volume":"7","author":"B Kulemann","year":"2017","unstructured":"Kulemann B, R\u00f6sch S, Seifert S et al (2017) Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations. Sci Rep\u2014UK 7:4510. https:\/\/doi.org\/10.1038\/s41598-017-04601-z","journal-title":"Sci Rep\u2014UK"},{"key":"21_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.canlet.2013.02.015","volume":"335","author":"F Fabbri","year":"2013","unstructured":"Fabbri F, Carloni S, Zoli W et al (2013) Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett 335:225\u2013231. https:\/\/doi.org\/10.1016\/j.canlet.2013.02.015","journal-title":"Cancer Lett"},{"key":"21_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5850-7","volume":"19","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yang Z, Wang Y et al (2019) Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer. BMC Cancer 19:651. https:\/\/doi.org\/10.1186\/s12885-019-5850-7","journal-title":"BMC Cancer"},{"key":"21_CR40","doi-asserted-by":"publisher","first-page":"21083","DOI":"10.1073\/pnas.1320659110","volume":"110","author":"X Ni","year":"2013","unstructured":"Ni X, Zhuo M, Su Z et al (2013) Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci USA 110:21083\u201321088. https:\/\/doi.org\/10.1073\/pnas.1320659110","journal-title":"Proc Natl Acad Sci USA"},{"key":"21_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","volume":"176","author":"S Gkountela","year":"2019","unstructured":"Gkountela S, Castro-Giner F, Szczerba BM et al (2019) Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell 176:98\u2013112.e14. https:\/\/doi.org\/10.1016\/j.cell.2018.11.046","journal-title":"Cell"},{"key":"21_CR42","doi-asserted-by":"publisher","first-page":"92483","DOI":"10.18632\/oncotarget.21426","volume":"5","author":"T Benezeder","year":"2014","unstructured":"Benezeder T, Tiran V, Treitler AAN et al (2014) Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients. Oncotarget 5:92483\u201392496. https:\/\/doi.org\/10.18632\/oncotarget.21426","journal-title":"Oncotarget"},{"key":"21_CR43","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1039\/c5lc01024a","volume":"15","author":"Z Ao","year":"2015","unstructured":"Ao Z, Parasido E, Rawal S et al (2015) Thermoresponsive release of viable microfiltrated circulating tumor cells (CTCs) for precision medicine applications. Lab Chip 15:4277\u20134282. https:\/\/doi.org\/10.1039\/c5lc01024a","journal-title":"Lab Chip"},{"key":"21_CR44","doi-asserted-by":"publisher","first-page":"15578","DOI":"10.18632\/oncotarget.3903","volume":"6","author":"BL Khoo","year":"2015","unstructured":"Khoo BL, Lee SC, Kumar P et al (2015) Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget 6:15578\u201315593. https:\/\/doi.org\/10.18632\/oncotarget.3903","journal-title":"Oncotarget"},{"key":"21_CR45","first-page":"1203","volume":"7","author":"K Kolostova","year":"2015","unstructured":"Kolostova K, Spicka J, Matkowski R, Bobek V (2015) Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers. Am J Transl Res 7:1203\u20131213","journal-title":"Am J Transl Res"},{"key":"21_CR46","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1158\/1078-0432.ccr-10-1105","volume":"16","author":"HK Lin","year":"2010","unstructured":"Lin HK, Zheng S, Williams AJ et al (2010) Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 16:5011\u20135018. https:\/\/doi.org\/10.1158\/1078-0432.ccr-10-1105","journal-title":"Clin Cancer Res"},{"key":"21_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba BM, Castro-Giner F, Vetter M et al (2019) Neutrophils escort circulating tumour cells\u00a0to enable cell cycle progression. Nature 566:553\u2013557. https:\/\/doi.org\/10.1038\/s41586-019-0915-y","journal-title":"Nature"},{"key":"21_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13402-019-00453-z","volume":"42","author":"A Salmaninejad","year":"2019","unstructured":"Salmaninejad A, Valilou SF, Soltani A et al (2019) Tumor-associated macrophages: role in cancer development and therapeutic implications. Cell Oncol 42:591\u2013608. https:\/\/doi.org\/10.1007\/s13402-019-00453-z","journal-title":"Cell Oncol"},{"key":"21_CR49","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.3390\/cancers12102784","volume":"12","author":"J Xiao","year":"2020","unstructured":"Xiao J, McGill JR, Stanton K et al (2020) Efficient propagation of circulating tumor cells: a first step for probing tumor metastasis. Cancers 12:2784. https:\/\/doi.org\/10.3390\/cancers12102784","journal-title":"Cancers"},{"key":"21_CR50","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/cancers13112668","volume":"13","author":"N Carmona-Ule","year":"2021","unstructured":"Carmona-Ule N, Gonz\u00e1lez-Conde M, Abu\u00edn C et al (2021) Short-term ex vivo culture of CTCs from advance breast cancer patients: clinical implications. Cancers 13:2668. https:\/\/doi.org\/10.3390\/cancers13112668","journal-title":"Cancers"},{"key":"21_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41598-019-57164-6","volume":"10","author":"D Brungs","year":"2020","unstructured":"Brungs D, Minaei E, Piper A-K et al (2020) Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer. Sci Rep\u2014UK 10:539. https:\/\/doi.org\/10.1038\/s41598-019-57164-6","journal-title":"Sci Rep\u2014UK"},{"key":"21_CR52","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/cancers12041011","volume":"12","author":"L Rivera-Baez","year":"2020","unstructured":"Rivera-Baez L, Lohse I, Lin E et al (2020) Expansion of circulating tumor cells from patients with locally advanced pancreatic cancer enable patient derived xenografts and functional studies for personalized medicine. Cancers 12:1011. https:\/\/doi.org\/10.3390\/cancers12041011","journal-title":"Cancers"},{"key":"21_CR53","doi-asserted-by":"publisher","first-page":"e11908","DOI":"10.15252\/emmm.201911908","volume":"12","author":"C Koch","year":"2020","unstructured":"Koch C, Kuske A, Joosse SA et al (2020) Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. Embo Mol Med 12:e11908. https:\/\/doi.org\/10.15252\/emmm.201911908","journal-title":"Embo Mol Med"},{"key":"21_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, Visser KE de (2016) Neutrophils in cancer: neutral no more. Nat Rev Cancer 16:431\u2013446. https:\/\/doi.org\/10.1038\/nrc.2016.52","journal-title":"Nat Rev Cancer"},{"key":"21_CR55","doi-asserted-by":"publisher","unstructured":"Sharma U, Medina-Saenz K, Miller PC et al (2021) Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis. Breast Cancer Res Treat 1\u201318. https:\/\/doi.org\/10.1007\/s10549-021-06299-0","DOI":"10.1007\/s10549-021-06299-0"},{"key":"21_CR56","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/cancers15061831","volume":"15","author":"J Xiao","year":"2023","unstructured":"Xiao J, Sharma U, Arab A et al (2023) Propagated circulating tumor cells uncover the potential role of NF\u03baB, EMT, and TGF\u03b2signaling pathways and COP1 in metastasis. Cancers 15:1831. https:\/\/doi.org\/10.3390\/cancers15061831","journal-title":"Cancers"},{"key":"21_CR57","doi-asserted-by":"publisher","first-page":"1773204","DOI":"10.1080\/2162402x.2020.1773204","volume":"9","author":"LA Aguirre","year":"2020","unstructured":"Aguirre LA, Montalb\u00e1n-Hern\u00e1ndez K, Avenda\u00f1o-Ortiz J et al (2020) Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells. Oncoimmunology 9:1773204. https:\/\/doi.org\/10.1080\/2162402x.2020.1773204","journal-title":"Oncoimmunology"},{"key":"21_CR58","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2147\/ott.s298427","volume":"14","author":"C-L Hu","year":"2021","unstructured":"Hu C-L, Zhang Y-J, Zhang X-F et al (2021) 3D culture of circulating tumor cells for evaluating early recurrence and metastasis in patients with hepatocellular carcinoma. Oncotargets Ther 14:2673\u20132688. https:\/\/doi.org\/10.2147\/ott.s298427","journal-title":"Oncotargets Ther"},{"key":"21_CR59","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.21873\/invivo.12404","volume":"35","author":"C Yang","year":"2021","unstructured":"Yang C, Kim I-H, Chae H et al (2021) Detection of circulating gastrointestinal cancer cells in conditionally reprogrammed cell culture. In Vivo 35:1515\u20131520. https:\/\/doi.org\/10.21873\/invivo.12404","journal-title":"In Vivo"},{"key":"21_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-022-02263-y","volume":"41","author":"MLD Angelis","year":"2022","unstructured":"Angelis MLD, Francescangeli F, Nicolazzo C et al (2022) An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile. J Exp Clin Cancer Res 41:86. https:\/\/doi.org\/10.1186\/s13046-022-02263-y","journal-title":"J Exp Clin Cancer Res"},{"key":"21_CR61","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ajpath.2011.10.036","volume":"180","author":"X Liu","year":"2012","unstructured":"Liu X, Ory V, Chapman S et al (2012) ROCK lls. Am J Pathol 180:599\u2013607. https:\/\/doi.org\/10.1016\/j.ajpath.2011.10.036","journal-title":"Am J Pathol"},{"key":"21_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34365-z","volume":"8","author":"A Soler","year":"2018","unstructured":"Soler A, Cayrefourcq L, Mazard T et al (2018) Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Sci Rep 8:15931. https:\/\/doi.org\/10.1038\/s41598-018-34365-z","journal-title":"Sci Rep"},{"key":"21_CR63","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.3390\/cancers13112723","volume":"13","author":"Y-P Yang","year":"2021","unstructured":"Yang Y-P, Giret TM, Cote RJ (2021) Circulating tumor cells from enumeration to analysis: current challenges and future opportunities. Cancers 13:2723. https:\/\/doi.org\/10.3390\/cancers13112723","journal-title":"Cancers"},{"key":"21_CR64","doi-asserted-by":"publisher","first-page":"20035","DOI":"10.1073\/pnas.1213241109","volume":"109","author":"FA Suprynowicz","year":"2012","unstructured":"Suprynowicz FA, Upadhyay G, Krawczyk E et al (2012) Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proc Natl Acad Sci USA 109:20035\u201320040. https:\/\/doi.org\/10.1073\/pnas.1213241109","journal-title":"Proc Natl Acad Sci USA"},{"key":"21_CR65","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1699-0463.1969.tb04520.x","volume":"77","author":"J Rygaard","year":"1969","unstructured":"Rygaard J, Poulsen CO (1969) Heterotransplantation of a human malignant tumour to \u201cNUDE\u201d mice. Acta Pathol Microbiol Scand 77:758\u2013760. https:\/\/doi.org\/10.1111\/j.1699-0463.1969.tb04520.x","journal-title":"Acta Pathol Microbiol Scand"},{"key":"21_CR66","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/mt.2012.73","volume":"20","author":"RA Morgan","year":"2012","unstructured":"Morgan RA (2012) Human tumor xenografts: the good, the bad, and the ugly. Mol Ther 20:882\u2013884. https:\/\/doi.org\/10.1038\/mt.2012.73","journal-title":"Mol Ther"},{"key":"21_CR67","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/hep.26151","volume":"57","author":"Y Sun","year":"2013","unstructured":"Sun Y, Xu Y, Yang X et al (2013) Circulating stem cell\u2013like epithelial cell adhesion molecule\u2013positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 57:1458\u20131468. https:\/\/doi.org\/10.1002\/hep.26151","journal-title":"Hepatology"},{"key":"21_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811x-8-20","volume":"8","author":"AD Donatis","year":"2010","unstructured":"Donatis AD, Ranaldi F, Cirri P (2010) Reciprocal control of cell proliferation and migration. Cell Commun Signal 8:20. https:\/\/doi.org\/10.1186\/1478-811x-8-20","journal-title":"Cell Commun Signal"},{"key":"21_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18632\/oncoscience.8","volume":"1","author":"E Rossi","year":"2014","unstructured":"Rossi E, Rugge M, Facchinetti A et al (2014) Retaining the long-survive capacity of circulating tumor cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients. Oncoscience 1:49\u201356. https:\/\/doi.org\/10.18632\/oncoscience.8","journal-title":"Oncoscience"},{"key":"21_CR70","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nm.3600","volume":"20","author":"CL Hodgkinson","year":"2014","unstructured":"Hodgkinson CL, Morrow CJ, Li Y et al (2014) Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 20:897\u2013903. https:\/\/doi.org\/10.1038\/nm.3600","journal-title":"Nat Med"},{"key":"21_CR71","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/annonc\/mdw122","volume":"27","author":"CJ Morrow","year":"2016","unstructured":"Morrow CJ, Trapani F, Metcalf RL et al (2016) Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol 27:1155\u20131160. https:\/\/doi.org\/10.1093\/annonc\/mdw122","journal-title":"Ann Oncol"},{"key":"21_CR72","doi-asserted-by":"publisher","unstructured":"Drapkin BJ, George J, Christensen CL et al (2018) Genomic and functional fidelity of small cell lung cancer patient-derived xenografts. Cancer Discov 8:CD-17-0935. https:\/\/doi.org\/10.1158\/2159-8290.cd-17-0935","DOI":"10.1158\/2159-8290.cd-17-0935"},{"key":"21_CR73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1158\/2159-8290.cd-15-1336","volume":"6","author":"MR Girotti","year":"2016","unstructured":"Girotti MR, Gremel G, Lee R et al (2016) Application of sequencing, liquid biopsies, and patient-derived xenografts for personalized medicine in melanoma. Cancer Discov 6:286\u2013299. https:\/\/doi.org\/10.1158\/2159-8290.cd-15-1336","journal-title":"Cancer Discov"},{"key":"21_CR74","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/ijc.32001","volume":"144","author":"T Pereira-Veiga","year":"2019","unstructured":"Pereira-Veiga T, Abreu M, Robledo D et al (2019) CTCs-derived xenograft development in a triple negative breast cancer case. Int J Cancer 144:2254\u20132265. https:\/\/doi.org\/10.1002\/ijc.32001","journal-title":"Int J Cancer"},{"key":"21_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-537","volume":"13","author":"N Dey","year":"2013","unstructured":"Dey N, Barwick BG, Moreno CS et al (2013) Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer 13: 537. https:\/\/doi.org\/10.1186\/1471-2407-13-537","journal-title":"BMC Cancer"},{"key":"21_CR76","doi-asserted-by":"publisher","first-page":"43124","DOI":"10.18632\/oncotarget.8988","volume":"7","author":"P De","year":"2016","unstructured":"De P, Carlson JH, Wu H et al (2016) Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers. Oncotarget 7:43124\u201343149. https:\/\/doi.org\/10.18632\/oncotarget.8988","journal-title":"Oncotarget"},{"key":"21_CR77","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/1878-0261.12533","volume":"13","author":"M Vishnoi","year":"2019","unstructured":"Vishnoi M, Liu NH, Yin W et al (2019) The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling. Mol Oncol 13:1913\u20131926. https:\/\/doi.org\/10.1002\/1878-0261.12533","journal-title":"Mol Oncol"},{"key":"21_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15426-2","volume":"11","author":"V Faugeroux","year":"2020","unstructured":"Faugeroux V, Pailler E, Oulhen M et al (2020) Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model. Nat Commun 11:1884. https:\/\/doi.org\/10.1038\/s41467-020-15426-2","journal-title":"Nat Commun"},{"key":"21_CR79","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1158\/1538-7445.am2024-2822","volume":"84","author":"L Martinetti","year":"2024","unstructured":"Martinetti L, Montagne P, Davilma M et al (2024) Abstract 2822: heterogeneity of CD56+ circulating tumor cells and derived xenografts and response to treatment in small cell lung cancer. Cancer Res 84:2822\u20132822. https:\/\/doi.org\/10.1158\/1538-7445.am2024-2822","journal-title":"Cancer Res"},{"key":"21_CR80","doi-asserted-by":"publisher","first-page":"i7","DOI":"10.1093\/noajnl\/vdae090.019","volume":"6","author":"V Law","year":"2024","unstructured":"Law V, Bayle S, Duckett D, Forsyth P (2024) BSLM-09 identification of drugs with selective activity against melanoma-associated leptomeningeal disease using patient-derived circulating tumor cells. Neuro-Oncol Adv 6:i7\u2013i7. https:\/\/doi.org\/10.1093\/noajnl\/vdae090.019","journal-title":"Neuro-Oncol Adv"},{"key":"21_CR81","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3390\/diagnostics13111855","volume":"13","author":"B Hong","year":"2023","unstructured":"Hong B, Zhang X, Du X et al (2023) Exploring the potential driver gene mutations that promote renal cancer cell metastasis and implantation based on circulating tumor cells culture. Diagnostics 13:1855. https:\/\/doi.org\/10.3390\/diagnostics13111855","journal-title":"Diagnostics"},{"key":"21_CR82","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1172\/jci67484","volume":"123","author":"J Cools-Lartigue","year":"2013","unstructured":"Cools-Lartigue J, Spicer J, McDonald B et al (2013) Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 123:3446\u20133458. https:\/\/doi.org\/10.1172\/jci67484","journal-title":"J Clin Invest"},{"key":"21_CR83","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/ijc.30635","volume":"140","author":"S Najmeh","year":"2017","unstructured":"Najmeh S, Cools-Lartigue J, Rayes RF et al (2017) Neutrophil extracellular traps sequester circulating tumor cells via \u03b21-integrin mediated interactions. Int J Cancer 140:2321\u20132330. https:\/\/doi.org\/10.1002\/ijc.30635","journal-title":"Int J Cancer"},{"key":"21_CR84","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nri3311","volume":"12","author":"LD Shultz","year":"2012","unstructured":"Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12:786\u2013798. https:\/\/doi.org\/10.1038\/nri3311","journal-title":"Nat Rev Immunol"},{"key":"21_CR85","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518\u2013524. https:\/\/doi.org\/10.1038\/nature03799","journal-title":"Nature"},{"key":"21_CR86","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537\u2013549. https:\/\/doi.org\/10.1016\/s1535-6108(03)00132-6","journal-title":"Cancer Cell"},{"key":"21_CR87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejca.2016.04.024","volume":"63","author":"M Ignatiadis","year":"2016","unstructured":"Ignatiadis M, Rack B, Roth\u00e9 F et al (2016) Liquid biopsy-based clinical research in early breast cancer: the EORTC 90091-10093 Treat CTC trial. Eur J Cancer 63:97\u2013104. https:\/\/doi.org\/10.1016\/j.ejca.2016.04.024","journal-title":"Eur J Cancer"},{"key":"21_CR88","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/annonc\/mdy211","volume":"29","author":"M Ignatiadis","year":"2018","unstructured":"Ignatiadis M, Liti\u00e8re S, Rothe F et al (2018) Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial. Ann Oncol 29:1777\u20131783. https:\/\/doi.org\/10.1093\/annonc\/mdy211","journal-title":"Ann Oncol"},{"key":"21_CR89","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.critrevonc.2012.05.002","volume":"84","author":"S Vignot","year":"2012","unstructured":"Vignot S, Besse B, Andr\u00e9 F et al (2012) Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers. Crit Rev Oncol Hematol 84:301\u2013313. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.05.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"21_CR90","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s43018-019-0020-z","volume":"1","author":"CA Stewart","year":"2020","unstructured":"Stewart CA, Gay CM, Xi Y et al (2020) Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer 1:423\u2013436. https:\/\/doi.org\/10.1038\/s43018-019-0020-z","journal-title":"Nat Cancer"},{"key":"21_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01553-5","volume":"21","author":"KN Suvilesh","year":"2022","unstructured":"Suvilesh KN, Nussbaum YI, Radhakrishnan V et al (2022) Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses. Mol Cancer 21:73. https:\/\/doi.org\/10.1186\/s12943-022-01553-5","journal-title":"Mol Cancer"}],"container-title":["Methods in Molecular Biology","Circulating Tumor Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5050-9_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:05:24Z","timestamp":1783634724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5050-9_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650493","9781071650509"],"references-count":91,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5050-9_21","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"3 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}